Cargando…
Evolution of blood–brain barrier in brain diseases and related systemic nanoscale brain-targeting drug delivery strategies
Blood–brain barrier (BBB) strictly controls matter exchange between blood and brain, and severely limits brain penetration of systemically administered drugs, resulting in ineffective drug therapy of brain diseases. However, during the onset and progression of brain diseases, BBB alterations evolve...
Autores principales: | Han, Liang, Jiang, Chen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8424230/ https://www.ncbi.nlm.nih.gov/pubmed/34522589 http://dx.doi.org/10.1016/j.apsb.2020.11.023 |
Ejemplares similares
-
Nanoscale drug delivery systems and the blood–brain barrier
por: Alyautdin, Renad, et al.
Publicado: (2014) -
Modulation of the Blood–Brain Barrier for Drug Delivery to Brain
por: Han, Liang
Publicado: (2021) -
Evolving Drug Delivery Strategies to Overcome the Blood Brain Barrier
por: Hersh, David S., et al.
Publicado: (2016) -
Established and Emerging Strategies for Drug Delivery Across the Blood-Brain Barrier in Brain Cancer
por: Parodi, Alessandro, et al.
Publicado: (2019) -
The Blood-Brain Barrier: Clinical Implications for Drug Delivery to the Brain
por: De Boer, A G, et al.
Publicado: (1994)